Key result
Modern management of atrial fibrillation emphasizes stroke risk assessment with CHA2DS2-VASc, use of novel oral anticoagulants for stroke prevention, and catheter ablation for rhythm control.
This review summarizes the European perspective on managing atrial fibrillation, focusing on stroke risk stratification, novel oral anticoagulants, and rhythm control strategies.
No takes yet. Share an insight, caveat, or question.
Consolidates European AF management for clinicians; leaves open prospective validation across diverse populations.
Kaba et al. (2013) conducted a review in Atrial fibrillation. Atrial fibrillation management (anticoagulants, antiarrhythmics, ablation) was evaluated. Modern management of atrial fibrillation emphasizes stroke risk assessment with CHA2DS2-VASc, use of novel oral anticoagulants for stroke prevention, and catheter ablation for rhythm control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: